ClinicalTrials.Veeva

Menu

Neuropsycholgy and Neuroimaging in Transient Global Amnesia (2NIA)

C

Caen University Hospital

Status

Terminated

Conditions

Transient Global Amnesia (TGA)

Treatments

Behavioral: Neuropsychological tests
Device: Cerebral imaging (MRI, PET-FDG)

Study type

Interventional

Funder types

Other

Identifiers

NCT02562560
2007-A00910-53

Details and patient eligibility

About

The purpose of this study is to establish a diagnosis in transient global amnesia (TGA) in assessing three episodic memory's abilities (mental simulation throught the future, and the past, the learning of personnal actions i-e the enactment effect). Secondary goal is to describe the neuronal substrates associated to the alteration of theses abilites in TGA.

Enrollment

60 patients

Sex

All

Ages

30 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All the participants

    • Minimum of 7 years of education
    • French native speaker
  • Healthy subjects : Non pathological Dementia rating scale score

  • Patients : Clinical diagnosis of TGA according to Hodges and Warlow's criterion

Exclusion criteria

  • Chronic neurological disease
  • Encephalitis
  • Endocrinal disease
  • Hepatic disease
  • Case history of head injury with loss of consciousness of more than one hour
  • Case history of stroke
  • Case history of cancer during the five last years except squamous cell carcinomas
  • Alcoholism or drug addiction
  • Major psychiatric disorders according the Diagnostic and Statistical Manual of -Mental Disorders

Trial design

60 participants in 2 patient groups

TGA
Experimental group
Treatment:
Device: Cerebral imaging (MRI, PET-FDG)
Behavioral: Neuropsychological tests
Controls
Experimental group
Treatment:
Device: Cerebral imaging (MRI, PET-FDG)
Behavioral: Neuropsychological tests

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems